Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDP323 Biomarker Study in Relapsing MS
NCT00726648Phase 2Completed
- Sponsor
- UCB
- Start
- Jul 2008
- Primary completion
- Mar 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zaurategrast in multiple sclerosis (MS), sponsored by UCB. Started Jul 2008; status: completed.
02
Drugs
zaurategrast
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00726648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726648.